Redeye initiates coverage of RaySearch, a software company offering treatment planning systems for radiotherapy clinics. We see good prospects for the company to extend its leadership position thanks to its resolute R&D-driven business model and strong value proposition. We expect increasing investor interest prompted by the quarterly reports (sales growth and EBIT margin expansion) and recognition of RaySearch’s high quality.

Read more and download the Research Report.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/